US10246444, Example 85;N-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]-3-cyano-7-[(2S)-2,3-dihydroxypropoxy]quinolin-6-yl]-2-[(3R)-dithiolan-3-yl]acetamide
1,2-dithiolane and dithiol compounds useful in treating mutant EGFR-mediated diseases and conditions
申请人:Sabila Biosciences LLC
公开号:US10246444B2
公开(公告)日:2019-04-02
Compositions of the invention comprise 1,2-dithiolane, dithiol and related compounds useful as therapeutic agents for the treatment and prevention of diseases and conditions associated with aberrant EGFR activity.